Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections. Bartoletti, M., Tedeschi, S., Pascale, R., Raumer, L., Maraolo, A. E., Palmiero, G., Tumietto, F., Cristini, F., Ambretti, S., Giannella, M., Lewis, R. E., & Viale, P. International Journal of Antimicrobial Agents, 51(3):516 – 521, 2018. Cited by: 2
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections [link]Paper  doi  bibtex   
@ARTICLE{Bartoletti2018516,
	author = {Bartoletti, Michele and Tedeschi, Sara and Pascale, Renato and Raumer, Luigi and Maraolo, Alberto Enrico and Palmiero, Giulia and Tumietto, Fabio and Cristini, Francesco and Ambretti, Simone and Giannella, Maddalena and Lewis, Russell Edward and Viale, Pierluigi},
	title = {Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections},
	year = {2018},
	journal = {International Journal of Antimicrobial Agents},
	volume = {51},
	number = {3},
	pages = {516 – 521},
	doi = {10.1016/j.ijantimicag.2018.01.010},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043374905&doi=10.1016%2fj.ijantimicag.2018.01.010&partnerID=40&md5=ceec083eee1d1b57c167a5ebd7ea2f4e},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 2}
}

Downloads: 0